The Department of Defense this week announced a notable contract award related to the field of chemical, biological, radiological and nuclear (CBRN) defense or life science research of interest for potential applications in biodefense:
The University of North Carolina at Chapel Hill, Chapel Hill, N.C. is being awarded an $18,242,644 modification to a cooperative agreement (HR0011-12-2-0001). The performer will provide a reconfigurable multi-element diagnostics platform. The fully integrated point of care (POC) platform will use highly multiplexed analysis of protein and nucleic acid biomarkers for the diagnosis of a selection of diseases relevant to the warfighter, as outlined by the Military Infectious Disease Research Program prioritized list of diseases and relevant to civilian POC diagnostics.
Work will be performed in Chapel Hill, N.C. (55 percent); Medford, Mass. (23 percent); Austin, Texas (2 percent); Cambridge, Mass. (17 percent) and Boulder, Colo. (3 percent). The estimated completion date is November, 2016. The contracting activity is the Defense Advanced Research Projects Agency, Arlington, Va.